MADISON, N.J. and AUSTIN, Texas, May 12, 2011 /PRNewswire/ -- A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of ...
MADISON, N.J. and FREMONT, Calif., March 9 /PRNewswire-FirstCall/ -- OVA1™, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding ...
MADISON, N.J. and FREMONT, Calif., Sept. 11 The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a ...
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the ...
A new study of OVA1® clinical performance, titled "The Effect of Ovarian Imaging on the Clinical Interpretation of a Multivariate Index Assay," has been released as an online advance publication of ...
(Medical Xpress) -- Researchers at Vermillion, a medical diagnostics company have announced that clinical trials for its OVA1® blood test diagnostic tool have shown promising results. The tool, part ...
A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than ...
Replacing CA125 with the OVA1 multivariate index assay may better predict whether an ovarian mass is cancerous in premenopausal women and those with early-stage disease, according to data from a study ...
AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered ...
Vermillion, Inc.'s OVA1® has received a new statement on clinical validation and medical use issued by the Society of Gynecologic Oncology (SGO). Citing peer-reviewed publications from two pivotal ...
Some of my best investments of the past were small companies that received FDA approval on a drug, a test, or some sort of procedure. The reaction to the excitement of this approval usually caused the ...
MADISON, N.J. and FREMONT, Calif., March 9 OVA1(TM), the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results